Literature DB >> 31773358

Different cortical excitability profiles in hereditary brain iron and copper accumulation.

Raffaele Dubbioso1, Lucia Ruggiero2, Marcello Esposito2, Paola Tarantino2, Marcello De Angelis2, Francesco Aruta2, Sabina Pappatà3, Lorenzo Ugga4, Alberto Piperno5, Raffaele Iorio6, Lucio Santoro2, Rosa Iodice2, Fiore Manganelli2.   

Abstract

BACKGROUND AND AIM: Neurodegeneration with brain iron accumulation (NBIA) and Wilson's disease (WD) is considered the prototype of neurodegenerative disorders characterised by the overloading of iron and copper in the central nervous system. Growing evidence has unveiled the involvement of these metals in brain cortical neurotransmission. Aim of this study was to assess cortical excitability profile due to copper and iron overload.
METHODS: Three patients affected by NBIA, namely two patients with a recessive hereditary parkinsonism (PARK9) and one patient with aceruloplasminemia and 7 patients with neurological WD underwent transcranial magnetic stimulation (TMS) protocols to assess cortical excitability. Specifically, we evaluated the motor thresholds that reflect membrane excitability related to the voltage-gated sodium channels in the neurons of the motor system and the ease of activation of motor cortex via glutamatergic networks, and ad hoc TMS protocols to probe inhibitory-GABAergic (short interval intracortical inhibition, SICI; short-latency afferent inhibition, SAI; cortical silent period, CSP) and excitatory intracortical circuitry (intracortical facilitation, ICF).
RESULTS: Patients with NBIA exhibited an abnormal prolongation of CSP respect to HC and WD patients. On the contrary, neurological WD displayed higher motor thresholds and reduced CSP and SICI.
CONCLUSION: Hereditary conditions due to overload of copper and iron exhibited peculiar cortical excitability profiles that can help during differential diagnosis between these conditions. Moreover, such results can give us more clues about the role of metals in acquired neurodegenerative disorders, such as Parkinson disease, Alzheimer disease, and multiple sclerosis.

Entities:  

Keywords:  GABA; Metals; NBIA; Neurodegeneration; TMS; Wilson’s disease

Mesh:

Substances:

Year:  2019        PMID: 31773358     DOI: 10.1007/s10072-019-04147-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

1.  Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy.

Authors:  Raffaele Dubbioso; Pasquale Moretta; Fiore Manganelli; Chiara Fiorillo; Rosa Iodice; Luigi Trojano; Lucio Santoro
Journal:  J Neurol       Date:  2011-09-29       Impact factor: 4.849

2.  Electrophysiological deterioration over time in patients with Huntington's disease.

Authors:  Jean-Pascal Lefaucheur; Isabelle Ménard-Lefaucheur; Patrick Maison; Sophie Baudic; Pierre Cesaro; Marc Peschanski; Anne-Catherine Bachoud-Lévi
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

3.  Motor pathway excitability in ATP13A2 mutation carriers: a transcranial magnetic stimulation study.

Authors:  S Zittel; J Kroeger; J P M van der Vegt; H R Siebner; N Brüggemann; A Ramirez; M I Behrens; C Gerloff; T Bäumer; C Klein; A Münchau
Journal:  Parkinsonism Relat Disord       Date:  2011-11-21       Impact factor: 4.891

4.  Electrophysiological characterisation in hereditary spastic paraplegia type 5.

Authors:  Fiore Manganelli; Chiara Pisciotta; Raffaele Dubbioso; Rosa Iodice; Chiara Criscuolo; Lucia Ruggiero; Giuseppe De Michele; Lucio Santoro
Journal:  Clin Neurophysiol       Date:  2010-12-15       Impact factor: 3.708

Review 5.  TMS and drugs revisited 2014.

Authors:  Ulf Ziemann; Janine Reis; Peter Schwenkreis; Mario Rosanova; Antonio Strafella; Radwa Badawy; Florian Müller-Dahlhaus
Journal:  Clin Neurophysiol       Date:  2014-12-04       Impact factor: 3.708

6.  Short-latency afferent inhibition in patients with Parkinson's disease and freezing of gait.

Authors:  Marina Picillo; Raffaele Dubbioso; Rosa Iodice; Alessandro Iavarone; Chiara Pisciotta; Emanuele Spina; Lucio Santoro; Paolo Barone; Marianna Amboni; Fiore Manganelli
Journal:  J Neural Transm (Vienna)       Date:  2015-07-31       Impact factor: 3.575

7.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.

Authors:  A McNeill; D Birchall; S J Hayflick; A Gregory; J F Schenk; E A Zimmerman; H Shang; H Miyajima; P F Chinnery
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

8.  Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle.

Authors:  R Cantello; M Gianelli; D Bettucci; C Civardi; M S De Angelis; R Mutani
Journal:  Neurology       Date:  1991-09       Impact factor: 9.910

9.  Cortical silent period prolongation in spinocerebellar ataxia type 2 (SCA2).

Authors:  Domenico A Restivo; Sara Lanza; Salvatore Giuffrida; Francesco Le Pira; Maria Teresa Drago; Rosario Di Mauro; Agostino Palmeri; Daniela Puzzo; Daniela Puzo; Paolo Di Bella; Edoardo Sessa; Carmela Rifici; Giangaetano D'Aleo; Nunzio Muscarà; Placido Bramanti
Journal:  Funct Neurol       Date:  2004 Jan-Mar

10.  Glutamate-mediated primary somatosensory cortex excitability correlated with circulating copper and ceruloplasmin.

Authors:  Franca Tecchio; Giovanni Assenza; Filippo Zappasodi; Stefania Mariani; Carlo Salustri; Rosanna Squitti
Journal:  Int J Alzheimers Dis       Date:  2011-11-21
View more
  2 in total

1.  Downregulation of CDK5 signaling in the dorsal striatum alters striatal microcircuits implicating the association of pathologies with circadian behavior in mice.

Authors:  Hu Zhou; Jingxin Zhang; Huaxiang Shi; Pengfei Li; Xin Sui; Yongan Wang; Liyun Wang
Journal:  Mol Brain       Date:  2022-06-14       Impact factor: 4.399

Review 2.  A comprehensive review of transcranial magnetic stimulation in secondary dementia.

Authors:  Giuseppe Lanza; Francesco Fisicaro; Raffaele Dubbioso; Federico Ranieri; Andrei V Chistyakov; Mariagiovanna Cantone; Manuela Pennisi; Alfio Antonio Grasso; Rita Bella; Vincenzo Di Lazzaro
Journal:  Front Aging Neurosci       Date:  2022-09-26       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.